Skip to content

Welcome to Discover Pharma! Today is : October 7, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

regulatory submissions

  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    PhaseV survey finds 88% of sponsors face five-week delays in clinical trial reporting

    A survey of more than 50 senior pharmaceutical and biotechnology [...]

    August 17, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Veristat launches AI biostatistics platform to accelerate clinical trial data readouts

    Veristat has launched an AI-enabled biostatistics platform designed to reduce [...]

    May 15, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Therapeutic Areas

    Veristat names Kim McLean Boericke as CEO to drive next phase of clinical research growtheristat names Kim McLean Boericke as CEO to drive next phase of clinical research growth

    Veristat, a global clinical research organization (CRO) and consultancy specializing [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    More than 450 companies adopt Veeva RIM to accelerate regulatory submissions

    Veeva Systems announced today that more than 450 companies, including [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development

    Certara expands clinical data collaboration with Merck to enhance digital trial efficiency

    Merck to broaden use of Certara’s Pinnacle 21 platform, adding [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Novadip secures €10.4M to advance pivotal Phase 3 trial
    Categories: Advanced Therapies, Biotech & Pharma Business, Clinical & Regulatory, Research & Development, Therapeutic Areas
  • Telix to acquire ITM in $1.65BN radiopharmaceutical deal
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Andelyn to manufacture FDA-approved Fayuvi gene therapy for Sanfilippo syndrome
    Categories: Advanced Therapies, Biotech & Pharma Business, Central Nervous System, Clinical & Regulatory, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top